ELV vs UNH: Elevance Health and UnitedHealth Group Chart Different Courses After Q3 Results
Key Takeaways
- ELV (Elevance Health) delivered a stronger-than-expected third quarter, lifted its 2026 adjusted earnings guidance, and pointed to at least 12% EPS growth for 2027.
- UNH (UnitedHealth Group) is further along in its margin-recovery effort, posting a notably better medical care ratio and marking its third guidance raise of the year.
- The two companies present distinct profiles: Elevance draws on a diversified insurance book plus its Carelon services platform, while UnitedHealth combines its insurance operations with the broader Optum healthcare-services ecosystem.
- Recent performance has diverged, with UnitedHealth mounting a sharper rebound from its lows while Elevance has maintained steadier, more diversified earnings momentum.
- Both face common sector challenges, including higher medical costs, Medicaid redetermination effects, and regulatory scrutiny around Medicare Advantage and pharmacy benefit managers.
- For additional details on each name, review ELV Major News and ELV Today's Price Move, or UNH Major News and UNH Today's Price Move.
- For automated, data-driven insights on these and thousands of other tickers, explore Trending AI Robots.
Introduction
Elevance Health and UnitedHealth Group rank among the largest publicly traded managed-care organizations in the United States, so this comparison matters for investors tracking the health-insurance sector. Both have worked through a challenging stretch marked by elevated medical utilization, policy changes, and regulatory pressure, yet their trajectories have begun to differ in meaningful ways. Long-term investors looking for steady compounders and traders monitoring relative performance can both gain from understanding how these bellwethers vary in business mix, growth drivers, and market positioning. The analysis that follows looks at recent results and observable trends to clarify how ELV and UNH compare at present. I also checked this using Tickeron’s AI Screener to see how the stocks line up against peers.
ELV Overview and Recent Performance
Elevance Health, which rebranded from Anthem in 2022, runs a diversified health-benefits operation across commercial, Medicaid, Medicare, and individual plans, together with its Carelon services business that includes pharmacy benefit management, behavioral health, and care delivery. In recent weeks, the company reported third-quarter results that exceeded consensus, with adjusted EPS of $6.99 versus roughly $4.70 expected and operating revenue near $50.4 billion. Management raised its full-year 2026 adjusted EPS guidance to at least $29.00 and improved its operating cash-flow outlook.
The quarter featured a 70-basis-point improvement in the benefit expense ratio to 90.6%, supported by stronger Medicare Advantage and individual-market results. Medical membership fell by about 487,000 year over year to roughly 44.9 million, reflecting a deliberate shift in positioning. Carelon helped diversify outcomes, with operating revenue rising 5% and operating gain advancing 17%. Analyst price-target increases have helped sentiment, although part of the earnings beat came from non-operating items, which tempered the market reaction.
UNH Overview and Recent Performance
UnitedHealth Group is the largest U.S. health insurer and a diversified healthcare enterprise that pairs its UnitedHealthcare insurance segment with the Optum platform covering Optum Health, Optum Rx, and Optum Insight. In recent weeks, the company reported third-quarter adjusted EPS of $4.69, well above the roughly $4.12–$4.14 consensus, on revenue of about $112.7 billion. It raised full-year 2026 adjusted EPS guidance to at least $20.50, marking the third increase this year.
The clearest development was margin recovery: the medical care ratio improved to 88.4% from 89.9% a year earlier, aided in part by favorable prior-period reserve development. Membership declined to about 48.3 million from 50.1 million as the firm intentionally exited unprofitable markets and plans. Optum Health showed a sharp swing, with operating earnings rising to roughly $735 million from $41 million a year earlier. Under returning CEO Stephen Hemsley, the company has emphasized profitability over enrollment growth, a move that has improved sentiment and supported a substantial rebound from 2025 lows.
Head-to-Head Comparison
The companies differ most clearly in scale and structure. UnitedHealth is roughly four times Elevance’s market capitalization and operates a larger, more integrated services engine through Optum. Elevance, by contrast, maintains a more balanced mix across commercial and government lines and leans heavily on Carelon for diversification. In growth drivers, Elevance is focused on margin expansion and Carelon cross-selling, while UnitedHealth is consolidating after a deliberate pullback from lower-margin business.
On recent momentum, UnitedHealth has posted the more dramatic recovery, rising substantially from its early-2026 trough as margin repair took hold. Elevance has been comparatively steadier, with gains linked to consistent earnings execution rather than a rebound narrative. Risk factors also vary in emphasis: Elevance carries notable Medicaid and state-rate sensitivity, whereas UnitedHealth faces the largest Medicare Advantage footprint and ongoing regulatory scrutiny. Valuation and dividend profiles differ as well, with UnitedHealth offering a higher yield and Elevance a lower payout ratio, reflecting distinct capital-return approaches. From what I see, these distinctions matter when weighing relative risk and reward.
Tickeron AI Verdict
Based on observable trend consistency, stability, and relative positioning, Tickeron’s AI would likely favor UnitedHealth Group at present, given its stronger established uptrend, improving margin trajectory, and clearer earnings-recovery catalysts across its insurance and Optum segments. Elevance Health remains a solid, well-diversified candidate with attractive long-term fundamentals, but its momentum has been less decisive and its recent beat partly reflected non-operating items. This assessment is probabilistic rather than definitive: both names carry exposure to medical-cost trends and policy risk, and relative positioning could shift as new data emerges. Traders and investors should weigh trend strength against valuation and their own objectives. I’m watching this closely for any signs of convergence or further divergence.
Exploring AI-Driven Trading Strategies
I’ve found that reviewing Tickeron’s Trending AI Robots page provides a useful snapshot of top-performing automated strategies across thousands of tickers. The platform hosts hundreds of AI trading bots, each with its own style, timeframe, performance record, and set of covered securities. Because market conditions shift, only the bots best suited to the current environment appear in the curated rankings. Checking these regularly helps identify approaches aligned with prevailing momentum and volatility.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
UNH in upward trend: price rose above 50-day moving average on October 14, 2026
UNH moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend. In 28 of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on UNH as a result. In 48 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 58%.
The Moving Average Convergence Divergence (MACD) for UNH just turned positive on October 05, 2026. Looking at past instances where UNH's MACD turned positive, the stock continued to rise in 25 of 45 cases over the following month. The odds of a continued upward trend are 56%.
The 10-day moving average for UNH crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 61%.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where UNH advanced for three days, in 182 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
Bearish Trend Analysis
The 10-day RSI Indicator for UNH moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 19 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
UNH broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for UNH entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 22 (best 1 - 100 worst), indicating outstanding price growth. UNH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.812) is normal, around the industry mean (3.556). P/E Ratio (26.801) is within average values for comparable stocks, (131.597). Projected Growth (PEG Ratio) (1.025) is also within normal values, averaging (0.786). UNH has a moderately high Dividend Yield (0.022) as compared to the industry average of (0.009). P/S Ratio (0.757) is also within normal values, averaging (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 90 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of hospital and medical service plans
Industry ManagedHealthCare
Advertisement